SG Americas Securities LLC Increases Position in LifePoint Health, Inc. (LPNT)
SG Americas Securities LLC increased its stake in LifePoint Health, Inc. (NASDAQ:LPNT) by 58.6% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 9,929 shares of the company’s stock after buying an additional 3,669 shares during the period. SG Americas Securities LLC’s holdings in LifePoint Health were worth $650,000 as of its most recent SEC filing.
Other large investors also recently modified their holdings of the company. US Bancorp DE boosted its stake in shares of LifePoint Health by 1.6% in the first quarter. US Bancorp DE now owns 1,931 shares of the company’s stock valued at $127,000 after buying an additional 30 shares in the last quarter. Bank of Montreal Can boosted its stake in shares of LifePoint Health by 18.7% in the first quarter. Bank of Montreal Can now owns 1,946 shares of the company’s stock valued at $128,000 after buying an additional 306 shares in the last quarter. Regent Investment Management LLC bought a new stake in shares of LifePoint Health during the first quarter valued at about $230,000. Fox Run Management L.L.C. bought a new stake in shares of LifePoint Health during the first quarter valued at about $255,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in shares of LifePoint Health during the fourth quarter valued at about $328,000. Institutional investors own 99.80% of the company’s stock.
LifePoint Health, Inc. (NASDAQ:LPNT) opened at 65.40 on Tuesday. LifePoint Health, Inc. has a 52-week low of $50.60 and a 52-week high of $70.95. The company has a market capitalization of $2.64 billion, a P/E ratio of 17.26 and a beta of 0.94. The firm has a 50-day moving average of $62.59 and a 200 day moving average of $61.46.
LifePoint Health (NASDAQ:LPNT) last released its quarterly earnings data on Friday, April 28th. The company reported $1.07 EPS for the quarter, beating the consensus estimate of $1.01 by $0.06. The business had revenue of $1.63 billion for the quarter, compared to the consensus estimate of $1.64 billion. LifePoint Health had a net margin of 2.26% and a return on equity of 7.06%. The business’s revenue for the quarter was up 3.1% on a year-over-year basis. During the same period in the prior year, the firm earned $0.85 EPS. Equities analysts predict that LifePoint Health, Inc. will post $4.20 earnings per share for the current fiscal year.
TRADEMARK VIOLATION WARNING: This piece was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://www.dailypolitical.com/2017/06/20/sg-americas-securities-llc-increases-position-in-lifepoint-health-inc-lpnt.html.
Several equities research analysts recently issued reports on LPNT shares. TheStreet upgraded shares of LifePoint Health from a “c+” rating to a “b-” rating in a report on Monday, March 13th. Morgan Stanley started coverage on shares of LifePoint Health in a report on Tuesday, June 6th. They issued an “equal weight” rating and a $65.00 target price on the stock. Barclays PLC raised their target price on shares of LifePoint Health from $58.00 to $60.00 and gave the stock an “equal weight” rating in a report on Monday, May 1st. BidaskClub upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Wednesday, June 14th. Finally, Zacks Investment Research upgraded shares of LifePoint Health from a “sell” rating to a “hold” rating in a report on Wednesday, February 22nd. Two investment analysts have rated the stock with a sell rating, eleven have given a hold rating and four have assigned a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average price target of $65.46.
In related news, Chairman William F. Carpenter III sold 82,347 shares of the stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $64.15, for a total transaction of $5,282,560.05. Following the sale, the chairman now directly owns 504,535 shares of the company’s stock, valued at $32,365,920.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, EVP John P. Bumpus sold 33,333 shares of the stock in a transaction on Thursday, March 30th. The stock was sold at an average price of $65.00, for a total transaction of $2,166,645.00. Following the sale, the executive vice president now directly owns 143,829 shares in the company, valued at $9,348,885. The disclosure for this sale can be found here. Insiders sold a total of 117,680 shares of company stock worth $7,574,965 over the last ninety days. Insiders own 7.28% of the company’s stock.
About LifePoint Health
LifePoint Health, Inc, through its subsidiaries, owns and operates community hospitals, regional health systems, physician practices, outpatient centers and post-acute facilities. As of December 31, 2016, the Company operated 72 hospital campuses in 22 states, having a total of 9,424 licensed beds. It offers a range of general and specialized healthcare services to patients through a network of hospitals and outpatient facilities.
Want to see what other hedge funds are holding LPNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LifePoint Health, Inc. (NASDAQ:LPNT).
Receive News & Ratings for LifePoint Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifePoint Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.